Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Biofortis Research

Neither a doctor nor a teaching hospital

Research payments

$99,279

115 payments

Through program year 2025, Biofortis Research is reported as receiving $99,279 in research payments, across 115 payments.

By program year

4 rows
Year Kind Amount Payments
2025 Research $12,614 1
2024 Research $19,798 3
2023 Research $10,051 2
2022 Research $56,817 109

Breakdown

Who paid Research payments · program years 2022–2025
  1. Novartis Pharmaceuticals Corporation $89,317 6 payments
  2. Novo Nordisk AS $9,963 109 payments
Studies the money was for Research payments · program years 2022–2025
  1. Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (Victorion-2 Prevent) $89,317 6 payments
  2. Nn9535-4984 $9,963 109 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record